MY172643A - Diagnosis of entamoeba histolytica - Google Patents
Diagnosis of entamoeba histolyticaInfo
- Publication number
- MY172643A MY172643A MYPI2011003202A MYPI2011003202A MY172643A MY 172643 A MY172643 A MY 172643A MY PI2011003202 A MYPI2011003202 A MY PI2011003202A MY PI2011003202 A MYPI2011003202 A MY PI2011003202A MY 172643 A MY172643 A MY 172643A
- Authority
- MY
- Malaysia
- Prior art keywords
- histolytica
- diagnosis
- entamoeba histolytica
- subject
- mutant
- Prior art date
Links
- 241000224432 Entamoeba histolytica Species 0.000 title abstract 5
- 229940007078 entamoeba histolytica Drugs 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2011003202A MY172643A (en) | 2011-07-07 | 2011-07-07 | Diagnosis of entamoeba histolytica |
| PCT/MY2011/000172 WO2013006024A1 (en) | 2011-07-07 | 2011-07-20 | Diagnosis of entamoeba histolytica |
| MX2014000007A MX358619B (es) | 2011-07-07 | 2011-07-20 | Diagnóstico de entamoeba histolytica. |
| IN626CHN2014 IN2014CN00626A (pt) | 2011-07-07 | 2011-07-20 | |
| BR112014000135A BR112014000135A2 (pt) | 2011-07-07 | 2011-07-20 | diagnóstico de entamoeba histolytica |
| CO14008609A CO6940378A2 (es) | 2011-07-07 | 2014-01-17 | Diagnóstico de entamoeba histolylica |
| ZA2014/00469A ZA201400469B (en) | 2011-07-07 | 2014-01-21 | Diagnosis of entamoeba histolytica |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2011003202A MY172643A (en) | 2011-07-07 | 2011-07-07 | Diagnosis of entamoeba histolytica |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY172643A true MY172643A (en) | 2019-12-07 |
Family
ID=47437247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2011003202A MY172643A (en) | 2011-07-07 | 2011-07-07 | Diagnosis of entamoeba histolytica |
Country Status (7)
| Country | Link |
|---|---|
| BR (1) | BR112014000135A2 (pt) |
| CO (1) | CO6940378A2 (pt) |
| IN (1) | IN2014CN00626A (pt) |
| MX (1) | MX358619B (pt) |
| MY (1) | MY172643A (pt) |
| WO (1) | WO2013006024A1 (pt) |
| ZA (1) | ZA201400469B (pt) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5130417A (en) * | 1990-04-30 | 1992-07-14 | Washington University | Entamoeba histolytical immunogenic protein and cdna clone |
| MX9206019A (es) * | 1992-10-20 | 1994-04-29 | Univ Autonoma De Nuevo Leon | Procedimiento para la preservacion de moleculas antigenicas sin el uso de inhibidores enzimaticos. |
-
2011
- 2011-07-07 MY MYPI2011003202A patent/MY172643A/en unknown
- 2011-07-20 MX MX2014000007A patent/MX358619B/es active IP Right Grant
- 2011-07-20 WO PCT/MY2011/000172 patent/WO2013006024A1/en active Application Filing
- 2011-07-20 IN IN626CHN2014 patent/IN2014CN00626A/en unknown
- 2011-07-20 BR BR112014000135A patent/BR112014000135A2/pt not_active Application Discontinuation
-
2014
- 2014-01-17 CO CO14008609A patent/CO6940378A2/es unknown
- 2014-01-21 ZA ZA2014/00469A patent/ZA201400469B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO6940378A2 (es) | 2014-05-09 |
| BR112014000135A2 (pt) | 2018-06-19 |
| MX358619B (es) | 2018-08-28 |
| ZA201400469B (en) | 2015-08-26 |
| IN2014CN00626A (pt) | 2015-04-03 |
| WO2013006024A1 (en) | 2013-01-10 |
| MX2014000007A (es) | 2015-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014031365A2 (pt) | métodos de detectar doenças ou condições | |
| EP2576833A4 (en) | METHOD AND DEVICE FOR THE POINT-OF-CARE DETECTION OF NUCLEIC ACID IN A SAMPLE | |
| EP2829881A3 (en) | Diagnostic for colorectal cancer | |
| WO2011119934A3 (en) | Methods and materials for detecting colorectal neoplasm | |
| WO2012054588A3 (en) | Conduit-containing devices and methods for analyte processing and detection | |
| WO2010056337A3 (en) | Methods and systems of using exosomes for determining phenotypes | |
| EP4234583A3 (en) | Evaluation and treatment of bradykinin-mediated disorders | |
| MX2014003422A (es) | Método para la monitorización, el diagnostico y/o el pronostico de lesión renal aguda en fase temprana. | |
| EP2569635A4 (en) | METHODS OF DIAGNOSING AND TREATING ENCEPHALITY OR EPILEPSY | |
| BR112012030788A2 (pt) | métodos de detecção de anticorpos monoclonais para enzimas que conferem resistência ao ácido 2,4-diclorofenoxiacético em plantas | |
| EP2566983A4 (en) | SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE | |
| PH12015502849B1 (en) | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
| TW200741203A (en) | Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody | |
| EA201500080A1 (ru) | Способ in vitro диагностирования и мониторинга рака | |
| MX339340B (es) | Metodos para predecir y mejorar la supervivencia de pacientes con cancer gastrico. | |
| MX2019002929A (es) | Biomarcadores de arn para angioedema hereditario. | |
| WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
| WO2012103337A3 (en) | Assays and methods to sequence microbes directly from immune complexes | |
| WO2015042326A3 (en) | Methods for detection and treatment of neurodegenerative diseases | |
| SG10201806729VA (en) | Novel assay to detect human periostin | |
| PH12014501445B1 (en) | Detection of human umbilical cord tissue-derived cells | |
| WO2011130647A3 (en) | Compositions and methods for characterizing a myopathy | |
| AU2013231230A8 (en) | Method for selecting or identifying a subject for V1B antagonist therapy | |
| MX2015007494A (es) | Metodo para diagnosticar leucodistrofia metacromatica. | |
| MY192159A (en) | Method for detecting neutralizing antibodies against recombinant human insulin in human serum |